Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Octreotide LA by Camurus for Neuroendocrine Tumors: Likelihood of Approval
Octreotide LA is under clinical development by Camurus and currently in Phase III for Neuroendocrine Tumors. According to GlobalData, Phase...
Octreotide LA by Camurus for Neuroendocrine Tumors: Likelihood of Approval
Octreotide LA is under clinical development by Camurus and currently in Phase III for Neuroendocrine Tumors. According to GlobalData, Phase...
Octreotide LA by Camurus for Acromegaly: Likelihood of Approval
Octreotide LA is under clinical development by Camurus and currently in Pre-Registration for Acromegaly. According to GlobalData, Pre-Registration drugs for...